In the SELECT trial, which ran from October 2018 through June 2023, researchers enrolled patients 45 years of age or older who had pre-existing cardiovascular disease and a body mass index of 27 or greater but no history of diabetes
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliski J
SAN FRANCISCO, July 1, 2025 (Newswire.com) - In This Article, You'll Discover: An overview of the innovative ReadyRx Glutathione Injection Program designed to support detoxification, longevity, and skin health How to seamlessly integrate the program into your daily meal routines for optimal results A breakdown of usage plans for: 3 months, 6 months, 12 months to help you select the most suitable option for your wellness goals Insights into building sustainable healthy habits that enhance overall wellness and quality of life in 2025 Crucial pricing information, including special introductory offers Key guidance for making informed purchasing decisions related to detox, longevity, and skin support treatments TL;DR The ReadyRx Glutathione Injection Program is designed to provide detoxification, longevity, and skin support

Inclusion Criteria Timeline for a Trial Participant Screening Participants are screened for eligibility to participate in the trial Treatment Participants receive tirzepatide and/or bimagrumab in addition to a lifestyle intervention for weight loss Follow-up Participants are monitored for safety and effectiveness after treatment What Are the Treatments Tested in This Trial
They bring a level of knowledge and care that's hard to find, and their treatments for PTSD and anxiety are nothing short of transformative